DK300483D0 - Fremgangsmade til fremstilling af trans-delta2-prostaglandin d derivater - Google Patents

Fremgangsmade til fremstilling af trans-delta2-prostaglandin d derivater

Info

Publication number
DK300483D0
DK300483D0 DK3004/83A DK300483A DK300483D0 DK 300483 D0 DK300483 D0 DK 300483D0 DK 3004/83 A DK3004/83 A DK 3004/83A DK 300483 A DK300483 A DK 300483A DK 300483 D0 DK300483 D0 DK 300483D0
Authority
DK
Denmark
Prior art keywords
delta2
prostaglandin
trans
derivatives
procedure
Prior art date
Application number
DK3004/83A
Other languages
English (en)
Other versions
DK300483A (da
Inventor
Hirohisa Wakatsuka
Takashi Yamato
Shinsuke Hashimoto
Original Assignee
Ono Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co filed Critical Ono Pharmaceutical Co
Publication of DK300483D0 publication Critical patent/DK300483D0/da
Publication of DK300483A publication Critical patent/DK300483A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0033—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing sulfur

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK300483A 1982-06-30 1983-06-29 Fremgangsmaade til fremstilling af trans-delta2-prostaglandin d derivater DK300483A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57112756A JPS595154A (ja) 1982-06-30 1982-06-30 プロスタグランジンｄ類似化合物

Publications (2)

Publication Number Publication Date
DK300483D0 true DK300483D0 (da) 1983-06-29
DK300483A DK300483A (da) 1983-12-31

Family

ID=14594754

Family Applications (1)

Application Number Title Priority Date Filing Date
DK300483A DK300483A (da) 1982-06-30 1983-06-29 Fremgangsmaade til fremstilling af trans-delta2-prostaglandin d derivater

Country Status (6)

Country Link
US (1) US4562204A (da)
EP (1) EP0099672A3 (da)
JP (1) JPS595154A (da)
AU (1) AU1631083A (da)
DK (1) DK300483A (da)
ZA (1) ZA834728B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3347128A1 (de) * 1983-12-22 1985-07-11 Schering AG, 1000 Berlin und 4709 Bergkamen 9-halogen-(delta)(pfeil hoch)2(pfeil hoch)-prostaglandinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
GB8410396D0 (en) * 1984-04-24 1984-05-31 Glaxo Group Ltd Carbocyclic compounds
DE3530821C2 (de) * 1985-08-29 1994-07-14 Merck Patent Gmbh Luprostiolhaltige Lösung
US20050112075A1 (en) * 2003-11-25 2005-05-26 Hwang Cheng S. Reduction of hair growth
US20050249685A1 (en) * 2004-04-27 2005-11-10 Natalia Botchkareva Reduction of hair growth
BRPI0519218A2 (pt) * 2004-12-22 2009-01-06 Gillette Co reduÇço do crescimento de cabelos ou pÊlos
WO2006069192A1 (en) * 2004-12-22 2006-06-29 The Gillette Company Reduction of hair growth with survivin inhibitors
US7618956B2 (en) * 2005-05-31 2009-11-17 The Gillette Company Reduction of hair growth
JP2016533329A (ja) * 2013-09-25 2016-10-27 ウィリアム マーシュ ライス ユニバーシティＷｉｌｌｉａｍ Ｍａｒｓｈ Ｒｉｃｅ Ｕｎｉｖｅｒｓｉｔｙ Δ１２−ｐｇｊ３および関連化合物の合成

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3931296A (en) * 1972-12-29 1976-01-06 Masaki Hayashi Trans-Δ2 -prostaglandins
US3954844A (en) * 1975-01-03 1976-05-04 G. D. Searle & Co. (5Z,13E,15S)-15-Hydroxy-11-oxoprosta-5,9.13-trien-1-oic acid and esters
US4123463A (en) * 1978-03-21 1978-10-31 The Upjohn Company 2-Decarboxy-2-alkylketone prostaglandins

Also Published As

Publication number Publication date
EP0099672A3 (en) 1984-10-24
AU1631083A (en) 1984-01-05
JPS595154A (ja) 1984-01-12
DK300483A (da) 1983-12-31
US4562204A (en) 1985-12-31
ZA834728B (en) 1984-03-28
JPH038339B2 (da) 1991-02-05
EP0099672A2 (en) 1984-02-01

Similar Documents

Publication Publication Date Title
DK301383D0 (da) Fremgangsmade til fremstilling af imidazolderivater
DK2281A (da) Fremgangsmaade til fremstilling af tiazolinderivater
DK95483A (da) Fremgangsmaade til fremstilling af tetrahydropyranderivater
DK161581A (da) Fremgangsmaade til fremstilling af imidazolderivater
DK100281A (da) Fremgangsmaade til fremstilling af imidazolderivater
DK241883D0 (da) Fremgangsmade til fremstilling af 1-sulfo-2-oxoazetidinderivater
DK372283A (da) Fremgangsmaade til fremstilling af desoxyuridinderivater
DK63683D0 (da) Fremgangsmade til fremstilling af cephemderivater
DK323083D0 (da) Fremgangsmade til fremstilling af 19-thio-androstanderivater
DK435483D0 (da) Fremgangsmade til fremstilling af fenylcyklobutylderivater
DK427083D0 (da) Fremgangsmade til fremstilling af cephemderivater
DK172181A (da) Fremgangsmaade til fremstilling af 9-carbamoyl-9-aminoalkylfluoren-derivater
DK261883A (da) Fremgangsmaade til fremstilling af prostaglandin-d-derivater
DK300483A (da) Fremgangsmaade til fremstilling af trans-delta2-prostaglandin d derivater
DK162230C (da) Fremgangsmaade til fremstilling af 2-thiacephemderivater
DK426683A (da) Fremgangsmaade til fremstilling af oxacephalosporinderivater
DK317283D0 (da) Fremgangsmade til fremstilling af thiadiazolderivater
DK340483D0 (da) Fremgangsmade til fremstilling af fluoralkylerede carbapenemderivater
DK482983A (da) Fremgangsmaade til fremstilling af phenylderivater
DK165583D0 (da) Fremgangsmade til fremstilling af furanderivater
DK299883A (da) Fremgangsmaade til fremstilling af prostaglandin d derivater
DK236683D0 (da) Fremgangsmade til fremstilling af trifenylbutenderivater
DK268981A (da) Fremgangsmaade til fremstilling af adeninnucleosidderivater
DK542383D0 (da) Fremgangsmade til fremstilling af acridanonderivater
DK128881A (da) Fremgangsmaade til fremstilling af thiophenderivater

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment